logo

For the Inventor, By the Inventor

Wallingford, PA, United States of America

George R Huggins

This inventor holds 7 USPTO granted patents. Top assignees: University of Pennsylvania, Monell Chemical Senses Center, University of Pa.. Active years: 1976-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George R Huggins. Retrieved from https://idiyas.com/inventor/george-r-huggins

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 118(Granted Patents)


Location History:

  • Parkton, MD (US) (1989)
  • Wallingford, PA (US) (1976 - 1990)

Company Filing History:

goldMedal5 out of 2,659 
 
University of Pennsylvania
 patents
silverMedal4 out of 51 
 
Monell Chemical Senses Center
 patents
bronzeMedal1 out of 6 
 
University of Pa.
 patents
where one patent can have more than one assignee

Years Active: 1976-1990

Loading Chart...
7 patents (USPTO):Explore Patents
1. 4931403 - Axillary androstenol and dehydroepiandrosterone as fertile period onset (1990-06-05),
2. 4879244 - Birth control method involving monitoring of axillary androstenol and (1989-11-07),
3. 4670401 - Axillary androstenol and dehydroepiandrosterone as fertile period onset (1987-06-02),
4. 4385125 - Method detecting ovulation by monitoring dodecanol concentration in (1983-05-24),
5. 4119089 - Method of predicting and determining ovulation by monitoring the (1978-10-10),
6. 4010738 - Method of predicting and detecting ovulation (1977-03-08),
7. 3986494 - Method of predicting and detecting ovulation (1976-10-19),

Title: The Innovative Work of George R. Huggins

Introduction

George R. Huggins, an influential inventor based in Wallingford, PA, has made significant contributions to the field of reproductive health through his pioneering innovations. With a total of seven patents to his name, Huggins has focused on the nuances of hormonal monitoring in women to provide more accurate indicators of fertility.

Latest Patents

Among Huggins' latest inventions are two notable patents centered on the monitoring of axillary androstenol and dehydroepiandrosterone sulfate to determine the onset of the fertile period in human females. His methods involve analyzing the variations in these hormone concentrations throughout the menstrual cycle. A significant peak in either compound's concentration after menstruation serves as an indicator of approaching ovulation. This innovation not only assists in predicting fertility but also helps in implementing effective contraceptive measures to avoid unwanted pregnancies.

Career Highlights

Huggins’ career includes affiliation with prominent research institutions such as the University of Pennsylvania and the Monell Chemical Senses Center, where he has conducted extensive research on chemical senses and hormonal influences. His work has had a profound impact on both academic and practical applications in reproductive health.

Collaborations

Throughout his career, Huggins has collaborated with esteemed colleagues, including George Preti and Winnifred B. Cutler. These partnerships have enriched his research and contributed to the successful development of his patented innovations.

Conclusion

George R. Huggins stands out as an innovative mind in the field of reproductive health. His patented methods of detecting the onset of fertility through hormonal monitoring hold promise for both individual reproductive planning and broader implications for family planning methods. As he continues to push the boundaries of innovation, Huggins remains a vital figure in the domain of reproductive health technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…